Shirokanedai Usui Building
6th Floor 3-16-13 Shirokanedai Minato-ku
Tokyo 108-0071
Japan
81 3 3440 3033
https://www.ribomic.com
Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 25
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Yoshikazu Nakamura Ph.D. | President & Representative Director | N/A | N/A | 1947 |
Mr. Masayuki Miyazaki | Executive Officer, GM of Business Administration Department | N/A | N/A | 1951 |
Hisato Oiwa | Executive Officer, GM of Management Headquarters & Director | N/A | N/A | 1958 |
Ribomic Inc. discovers and develops pharmaceutical compounds using RNA aptamers in Japan. The company develops drugs for wet age-related macular degeneration, achondroplasia, pulmonary arterial hypertension, proliferative vitreoretinopathy, heart failure, osteoarthritis, and asthma, as well as separating agents for affinity purification of human IgG and Fc-fusion proteins. Ribomic Inc. was incorporated in 2003 and is headquartered in Tokyo, Japan.
Ribomic Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.